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In a previous study, we showed that the inositol pyrophosphate
diphosphoinositol pentakisphosphate (IP7) physiologically phosphor-
ylates mammalian and yeast proteins. We now report that this
phosphate transfer reflects pyrophosphorylation. Thus, proteins
must be prephosphorylated by ATP to prime them for IP7 phosphor-
ylation. IP7 phosphorylates synthetic phosphopeptides but not if their
phosphates have been masked by methylation or pyrophosphoryla-
tion. Moreover, IP7 phosphorylated peptides are more acid-labile and
more resistant to phosphatases than ATP phosphorylated peptides,
indicating a different type of phosphate bond. Pyrophosphorylation
may represent a novel mode of signaling to proteins.
inositol polyphosphate  protein phosphorylation
Inositol phosphates have diverse biologic roles with the bestknown, inositol-1,4,5-trisphosphate (IP3), releasing intracellu-
lar calcium (1). Inositol pyrophosphates (also designated inositol
diphosphates), exemplified by diphosphoinositol pentakisphos-
phate (5-PP-I(1,2,3,4,6)P5, hereafter called IP7) and bis-
diphosphoinositol tetrakisphosphate ([PP]2-IP4, IP8) (2–4) are
formed by a group of three inositol hexakisphosphate (IP6)
kinases (IP6Ks) (5–7). IP6K and inositol pyrophosphates par-
ticipate in diverse physiologic activities including endocytosis (8,
9), apoptosis (10, 11), chemotaxis (12), and telomere elongation
(13, 14). Recently, a novel inositol pyrophosphate, 4/6-PP-IP5,
synthesized by the Vip1 protein in Saccharomyces cerevisiae, was
identified by York and associates (15, 16) and shown to be
involved in regulating cell growth, morphology, and phosphate
homeostasis in yeast.
The pyrophosphate bond of IP7 has a calculated phosphory-
lation potential that equals or exceeds that of ATP, suggesting
that it could serve a similar function (4, 17). We demonstrated
that IP7 physiologically phosphorylates a variety of protein
targets in yeast and mammals (18). Unlike phosphorylation by
ATP, IP7 does not require separate protein kinases but directly
phosphorylates its targets. We wondered how signaling by IP7
phosphorylation is distinguished from phosphorylation by ATP.
We now report that protein phosphorylation by IP7 involves a
novel modification, pyrophosphorylation, which may provide a
unique mode of signaling to proteins.
Results and Discussion
In our earlier study, we showed that 5[32P]IP7 phosphorylates
a wide range of proteins in both the yeast, S. cerevisiae, and in
mammalian tissues (18). We characterized in detail phosphor-
ylation of several of these proteins, such as the yeast proteins
NSR1 and SRP40. To obtain large amounts of these proteins, we
expressed them in Escherichia coli (Fig. 1a). Whereas these
proteins purified from yeast are robustly phosphorylated by
5[32P]IP7, the corresponding proteins purified from bacteria
display no phosphorylation. What property of yeast but not
bacterial extracts conveys the capacity for IP7 phosphorylation?
One distinction is that proteins in yeast may be prephosphory-
lated whereas eukaryotic proteins are unlikely to be phosphor-
ylated in E. coli. We examined whether yeast extracts influence
IP7 phosphorylation of proteins purified from E. coli (Fig. 1b).
Although yeast extracts alone do not augment IP7 phosphory-
lation, yeast extracts plus ATP allow IP7 phosphorylation of
proteins purified from bacteria comparable to phosphorylation
of the same proteins purified from yeast. Boiled yeast extracts
fail to prime proteins for IP7 phosphorylation, indicating that the
critical factor may be a protein, possibly an enzyme (Fig. 1c).
Several lines of evidence indicate that prephosphorylation of
proteins primes them for IP7 phosphorylation. ATP and GTP,
which can donate phosphate groups, provide priming activity,
whereas AMP-PNP, which is nonhydrolyzable, is inactive, as is
UTP, a poor substrate for protein kinases (Fig. 1d). CK2
(formerly casein kinase-2) is one of the few protein kinases for
which GTP donates phosphate to a comparable extent as ATP
(19). Because GTP primes IP7 phosphorylation as well as ATP,
we examined the priming activity of CK2 on the IP7 phosphor-
ylation of NSR1 (1–50), a fragment of NSR1 which is an excellent
substrate for IP7 phosphorylation [supporting information (SI)
Fig. 5] and has a strong consensus motif for CK2 phosphoryla-
tion. CK2 robustly primes IP7 phosphorylation (Fig. 1e). Fur-
thermore, the IP7 substrate NSR1 (27–50) (SI Fig. 5), can be
directly phosphorylated by IP7 when purified from E. coli that
coexpress the catalytic subunit of CK2 (Fig. 1f ). If prephospho-
rylation is the critical priming event for IP7 phosphorylation,
then dephosphorylation should prevent such priming. Dephos-
phorylation of NSR1 (51–166) or NSR1 (1–50) by -phosphatase
greatly reduces IP7 phosphorylation (Fig. 1g). Protein kinase-
mediated priming for IP7 phosphorylation is observed for all IP7
substrates tested, including yeast SRP40, NSR1, YGR130c, and
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APL6 and mammalian Nopp140, AP33A, and TCOF1 (data
not shown).
The requirement for priming by prephosphorylation suggests
that either (i) ATP phosphorylation at certain sites allosterically
facilitates IP7-mediated phosphorylation at other sites, or (ii) IP7
directly phosphorylates amino acids that have been previously
ATP-phosphorylated and hence provides a pyrophosphorylation
or diphosphorylation modification. Earlier, we noted that IP7
phosphorylation occurs primarily at stretches of serines flanked
by acidic amino acids and concluded that phosphorylation occurs
on the serine residues (18) (also see SI Fig. 6). In Nopp140,
deletion of individual serine residues in such a stretch (amino
acid 80–100) decreases IP7 phosphorylation, implying that IP7
can phosphorylate several of them (Fig. 2a). Substitution of the
single threonine residue in this sequence has no effect on IP7
phosphorylation. Because prephosphorylation by CK2 leads to
IP7-mediated phosphorylation of such sites, Nopp140 fragments
containing phosphates at the CK2-preferred sites should be
substrates for IP7 phosphorylation in the absence of any other
priming. To identify the preferred sites for CK2 phosphoryla-
tion, we phosphorylated an E. coli-expressed Nopp140 fragment
comprising amino acids 80–100 and identified the major phos-
phorylation sites by mass spectrometry as serines 88 and 91 (data
not shown). We synthesized a peptide with both of these serines
prephosphorylated (Fig. 2b). This phosphopeptide is robustly
phosphorylated by 5[32P]IP7, whereas the corresponding un-
phosphorylated peptide is resistant to 5[32P]IP7 phosphoryla-
tion (Fig. 2c). Using two peptides with phosphates at serines 88
and 91, respectively, we observe substantially greater phosphor-
ylation at position 91 than 88 (Fig. 2c). This differential influence
on discrete sites supports the specificity of IP7-mediated phos-
phorylation. Both the unphosphorylated and phosphorylated
peptides are phosphorylated by [32P]ATP and CK2 (Fig. 2d) on
one ormore of the available serine residues (data not shown). IP7
Fig. 1. IP7-mediated protein phosphorylation requires prephosphorylation by protein kinases. (a) NSR1 and SRP40 purified from E. coli or S. cerevisiae were
incubated with 5[32P]IP7 and resolved by NuPAGE; immunoblotting with a tag-specific antibody (Left) and autoradiography to determine phosphorylation
(Right). (b) GST or GST-tagged NSR1 fragment (amino acids 51–166) expressed inE. coliand immobilized on glutathione beads were preincubated with or without
S. cerevisiae extract or ATP, washed with PBS, and then treated with 5[32P]IP7 and resolved by NuPAGE; Coomassie brilliant blue R250 staining (Left) and
autoradiography (Right). The extra phosphorylated protein bands in lanes 3–6 are yeast proteins that bound nonspecifically to glutathione beads. (c) GST-SRP40
purified from E. coli was preincubated with ATP and either native S. cerevisiae extract (N) or extract that had been boiled for 5 min (B) and then treated with
5[32P]IP7 as in b. (d) GST-SRP40 purified from E. coli was preincubated with yeast extract and indicated nucleotides and then phosphorylated by 5[32P]IP7;Coo-
massie brilliant blue R250 staining (Lower) and autoradiography (Upper). (e) GST or GST-tagged NSR1 fragment (amino acids 1–50) purified from E. coli were
preincubated with or without CK2 and ATP and then treated with 5[32P]IP7 as in b. ( f) GST-tagged NSR1 fragment (amino acids 27–50) purified from E. coli was
incubated without or with CK2 and ATP (lanes 1 and 2) or coexpressed in E. coli with the catalytic A1 subunit of human CK2 (lane 3). Purified proteins were
incubated with 5[32P]IP7 as in b. (g) GST or GST-tagged NSR1 fragments (amino acids 1–50 and 51–166) purified from S. cerevisiae, were preincubated in the
absence or presence of -phosphatase and then phosphorylated by 5[32P]IP7 as in b.
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phosphorylation of the prephosphorylated but not the unphos-
phorylated Nopp140 peptide is consistent with pyrophosphory-
lation. This possibility is further supported bymass spectrometric
analysis showing no phosphorylation by IP7 of the unphosphor-
ylated Nopp140 peptide but addition of one or two phosphates
to the prephosphorylated peptides (SI Table 1). The maximum
number of phosphates accepted by a peptide from IP7 equals the
number of preexisting phosphate groups on the peptide; single
phosphoserine-containing peptides accept one phosphate from
IP7, whereas the peptide containing two phosphoserine residues
accepts one or two phosphates.
The phosphorylated Nopp140 peptide might facilitate IP7
phosphorylation of nearby serines or might be pyrophosphory-
lated. To distinguish those alternatives, we synthesized the same
phosphopeptide in which the two phosphates have been meth-
ylated to prevent pyrophosphorylation (Fig. 2b). The methylated
phosphopeptide is not phosphorylated by 5[32P]IP7 (Fig. 2c and
SI Table 1), although it can be phosphorylated by [32P]ATP and
CK2 (Fig. 2d).
The failure of the methylated phosphopeptide to be IP7-
phosphorylated strongly implies that IP7 provides pyrophospho-
rylation. To further test this possibility, we synthesized the same
Nopp140 peptide in which both serines 88 and 91 are pyrophos-
phorylated. This pyrophosphorylated peptide resists IP7 phos-
phorylation, although it can be phosphorylated by CK2 (Fig. 2
c and d and SI Table 1). This further supports the notion that IP7
pyrophosphorylates its targets.
If IP7 phosphorylates proteins on serines in the same fashion
as ATP, then the properties of the phosphoserine bond should
be the same with IP7 and ATP phosphorylation. By contrast, the
chemical properties of a pyrophosphorylated serine should differ
from those of a conventional phosphoserine. We examined the
acid sensitivity of the phospho-Nopp140 peptide after phosphor-
ylation by [32P]ATP and CK2 or 5[32P]IP7 (Fig. 3 a and b).
Phosphorylation by 5[32P]IP7 is more labile to treatment with
3 M HCl compared with phosphorylation by [32P]ATP and
CK2. Furthermore, we subjected the CK2 and ATP or IP7-
phosphorylated peptides to hydrolysis in the presence of 6 M
HCl to release single amino acids. Hydrolysis liberates a prom-
inent peak of [32P]phosphoserine from the ATP-phosphorylated
peptide but not from the IP7-phosphorylated peptide (Fig. 3
c–e). Thus, the pyrophosphate modification on serine is more
labile to acid than the conventional phosphoserine elicited by
ATP-mediated phosphorylation.
In contrast to the greater lability to acid treatment, the
IP7-phosphorylated peptide is more stable to enzymatic dephos-
phorylation (Fig. 4a). As observed earlier (Fig. 1g), -phospha-
tase treatment before adding IP7 prevents IP7 phosphorylation
of NSR1 (1–50). After IP7 phosphorylation, however, the protein
is completely resistant to -phosphatase. -Phosphatase greatly
reduces phosphorylation of CK2 and ATP phosphorylated
NSR1 (27–50) or Nopp140 peptide but fails to affect the
IP7-phosphorylated peptides (Fig. 4 b and c). The same protein
fragments are resistant to -phosphatase when purified from
yeast labeled with inorganic orthophosphate [32PO4]i (Fig. 4d),
implying that these proteins exist within yeast cells in a pyro-
phosphorylated form.
These experiments suggest that the pyrophosphoserine bond
is resistant to -phosphatase. We directly tested this possibility
using the Nopp140 peptide containing pyrophosphorylated
serines at position 88 and 91 compared with the same peptide
with phosphorylated serines at these positions. -Phosphatase
abolishes phosphorylation of the phospho-Nopp140 peptide but
does not affect the pyrophosphorylated Nopp140 peptide (Fig.
4e and SI Table 2).
We also examined the sensitivity of the IP7-phosphorylated
NSR1 (27–50) fragment to other protein phosphatases. The
following protein phosphatases are completely inactive: cal-
cineurin, protein phosphatase-1, and alkaline phosphatase (SI
Fig. 7a). In addition, the pyrophosphatase enzymes, thermo-
stable inorganic pyrophosphatase and tobacco acid pyrophos-
phatase, fail to dephosphorylate the IP7-phosphorylated peptide
(SI Fig. 7a). Because these enzymes hydrolyze inorganic pyro-
phosphate (PPi), it is likely that they do not recognize pyro-
phosphate linked to a serine residue. We also studied DIPP
(diphosphoinositol polyphosphate phosphohydrolase), an en-
zyme that Shears and associates (20, 21) have shown to physi-
ologically dephosphorylate IP7. As expected, pretreatment of the
reaction mix containing IP7 lowers phosphorylation, whereas
treatment with DIPP after IP7 phosphorylation has no effect
(SI Fig. 7b).
In summary, we report that IP7 pyrophosphorylates proteins.
Evidence includes the requirement of prephosphorylation by
ATP to prime proteins for IP7 phosphorylation and the selective
phosphorylation by IP7 of synthetic phosphopeptides but not of
Fig. 2. IP7 phosphorylates a phosphoserine residue to generate pyrophosphoserine. (a) Extracts from S. cerevisiae expressing GST-tagged mouse Nopp140
fragment (amino acids 80–100) WT sequence and indicated point mutants were phosphorylated by 5[32P]IP7; autoradiography (Upper) and immunoblotting
(Lower). (b) Sequences of individual peptides derived from Nopp140 (GenBank accession no. NP941035). NOP, amino acids 76–100 of mouse Nopp140;
NOP-2[pS], the same sequence as NOP except with phosphoserine at positions 88 and 91; NOP-pS 88 and NOP-pS 91, single phosphoserine residues at positions
88 and 91 respectively; NOP-2[MepS], methylphosphoserine at positions 88 and 91; NOP-2[ppS], pyrophosphoserine at positions 88 and 91. (c and d) The six
synthetic peptides in b were incubated with 5[32P]IP7 (c) or with CK2 and [32P]ATP (d) and resolved by NuPAGE. Coomassie G250 staining (Left) and
autoradiography (Right). In each peptide lane, there are multiple bands in the 3- to 9-kDa range, corresponding to peptide monomers and multimers, generated
possibly because of electrostatic interactions between the positively charged lysines and negatively charged acidic and phosphate-containing residues (27).
Peptide dimers were also observed by MALDI-TOF analysis (data not shown).
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such peptides that are ‘‘blocked’’ by methylation or are already
pyrophosphorylated. Moreover, the properties of IP7-
phosphorylated peptides differ markedly from ATP-phosphor-
ylated peptides in terms of acid lability, which is greater with
IP7-phosphorylated peptides, and sensitivity to phosphatases,
which is much less with IP7-phosphorylated peptides.
We wondered whether 4/6-PP-IP5, the novel isomer of IP7
identified by York and colleagues (15), and IP8 are able to
phosphorylate proteins in a manner similar to 5-PP-IP5. Radio-
labeled 4/6-PP-IP5 and IP8 phosphorylate proteins in extracts
obtained from S. cerevisiae (SI Fig. 8), the pattern of phosphor-
ylated proteins being identical to that obtained with 5-PP-IP5.
Fig. 3. The properties of pyrophosphoserine differ from those of phosphoserine. (a and b) NOP-2[pS] peptide was phosphorylated by CK2 and [32P]ATP (a)
or by 5[32P]IP7 (b), then treated with HCl and subjected to NuPAGE; Coomassie G250 staining (Left) and autoradiography (Right). (c) NOP-2[pS] peptide was
phosphorylated by either CK2 and [32P]ATP or by 5[32P]IP7 as described in SI Materials andMethods. A fraction of the phosphorylated peptides was subjected
to NuPAGE to ensure equivalent phosphorylation under both conditions; Coomassie G250 staining (Left) and autoradiography (Right). (d and e) The remaining
CK2 phosphorylated peptide (d) and IP7-phosphorylated peptide (e) were hydrolyzed with 6 M HCl, and the resulting amino acids were resolved by HPLC. Data
collected during the first 40 min of the HPLC run are presented; elution profiles of the first 3 aa (Upper) and corresponding radioactivity in each 1-ml fraction
(Lower). Note that high levels of 32Pi in the IP7-phosphorylated sample compared with the CK2 and ATP phosphorylated sample are due to incomplete removal
of 5[32P]IP7 from the peptide during desalting (see SI Materials and Methods).
Fig. 4. -phosphatase does not dephosphorylate IP7-phosphorylated proteins. (a) GST-tagged NSR1 fragment (amino acids 1–50) purified from S. cerevisiae
was incubated without or with -phosphatase and then phosphorylated by 5[32P]IP7 (lanes 1 and 2). Alternatively, the protein was first phosphorylated by
5[32P]IP7 and then incubated without or with -phosphatase (lanes 3 and 4). The samples were resolved by NuPAGE and autoradiographed. (b) GST-tagged NSR1
fragment (amino acids 27–50) purified from S. cerevisiaewas phosphorylated either by CK2 and [32P]ATP (Left) or by 5[32P]IP7 (Right) and then incubated with
or without -phosphatase; Coomassie G250 staining (Left) and autoradiography (Right). (c) NOP-2[pS] peptide bound to streptavidin agarose beads was
phosphorylated by either CK2 and [32P]ATP (Left) or by 5[32P]IP7 (Right) and then incubated with or without -phosphatase as in b. (d) S. cerevisiae expressing
GST-tagged Nopp140 fragment (amino acids 80–100) (Left) or NSR1 fragment (amino acids 27–50) (Right) were labeled with inorganic orthophosphate [32PO4]i.
Purified radiolabeled proteins were incubated with or without -phosphatase; autoradiography (Upper) and immunoblotting (Lower). (e) NOP-2[pS] peptide
(Left) or NOP-2[ppS] peptide (Right) were treated with or without -phosphatase, resolved by NuPAGE, and stained with either Coomassie G250 or Pro-Q
Diamond phosphoprotein gel stain, as indicated.
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Therefore, it is likely that the principal known inositol pyro-
phosphates are able to pyrophosphorylate proteins.
Nonenzymatic pyrophosphorylation is thermodynamically
feasible. Semiempirical calculations show that, whereas the free
enthalpy (H) of reaction for transfer of the -phosphate from
IP7 to a simple primary alcohol is pH- and counterion-
dependent, H values at pH 6.8 can reach 38.3 kcal/mol (17).
This strongly exothermic reaction equals or exceeds H for
phosphorylation by ATP. The high phosphorylation potential is
attributable to the sterically and electronically crowded envi-
ronment of the IP7 pyrophosphate group. The phosphoserine to
pyrophosphoserine conversion by IP7 will require more ad-
vanced modeling, but two important clues emerge from the
protein substrates for IP7 that suggest how the 3D structures of
the polypeptide may organize reagent and substrate to provide
an entropic driving force to contribute to the overall free energy
(G) for the reaction. First, the polyserine tracts must have Asp
or Glu residues present for pyrophosphorylation to occur.
Second, the pyrophosphorylation shows an absolute require-
ment for divalent cations, with Mg2 preferred (18). Both of
these features are reminiscent of the prenyl diphosphate syn-
thases, which feature DDXXD motifs that coordinate Mg2,
which in turn activates the pyrophosphate as a leaving group
(22). For serine pyrophosphorylation, one can imagine IP7
phosphates organized by H-bonds within a polySer tract,
whereas the IP7 pyrophosphate could be activated and targeted
to a particular phosphoserine phosphate with the assistance of an
Asp/Glu-chelated Mg2.
What might be the physiologic role of pyrophosphorylation?
Classic protein kinase-mediated phosphorylation modifies the
conformation of proteins, enhancing or decreasing catalytic
activity, determining protein localization, or altering protein–
protein interactions. Presumably pyrophosphorylation also elic-
its such alterations in protein function. ATP-mediated phos-
phorylation is typically regulated by dephosphorylation, whereas
pyrophosphorylated proteins are resistant to known protein
phosphatases. This suggests that serine pyrophosphorylation
may be a more stable modification within the cell, even though
it is thermodynamically more unstable compared with phospho-
serine. Such a conclusion is consistent with the fact that some of
the best IP7 targets, such as NSR1 and SRP40/Nopp140, exist
endogenously as abundantly phosphorylated proteins (23–25).
Although it is likely that pyrophosphorylation plays a central role
in cellular processes modulated by inositol pyrophosphates, at
this time, the biological significance of this modification remains
unclear.
Materials and Methods
Synthesis of Inositol Pyrophosphate. The inositol pyrophosphate
used throughout these studies was 5-PP-I(1,2,3,4,6)P5 (referred
to as IP7). The synthesis and purification of radiolabeled
5[32P]IP7 was carried out as described earlier (18). By using
these procedures, 5[32P]IP7 was obtained at a specific activity
of 60 Ci/mmol (1 Ci 37 GBq) and used at 1–2 Ci per reaction
for protein phosphorylation. The synthesis of 32P-labeled 4/6-
PP-IP5 and IP8 is described in SI Materials and Methods. Unla-
beled 5-PP-I(1,2,3,4,6)P5 was prepared by total synthesis by using
modifications of an earlier method (26). Full experimental
details are provided in SI Materials and Methods.
Preparation of Recombinant Proteins. The expression and purifi-
cation of all recombinant proteins are described in SI Materials
and Methods.
Protein and Peptide Phosphorylation Assays. Cell lysates were ob-
tained by resuspending yeast cells in ice-cold lysis buffer [20 mM
Hepes (pH 6.8)/5 mM DTT/1 mM EGTA/1 mM EDTA/0.1%
CHAPS, protease inhibitor mixture, and 200 mg/liter phenyl-
methanesulfonyl f luoride] and vortexing the sample in the
presence of glass beads. The homogenates were centrifuged for
20 min at 15,000  g, and supernatants were used in the assay.
In experiments where lysates were used directly for phosphor-
ylation, protein extracts (10–20 g) were incubated in IP7
phosphorylation buffer [25 mM Hepes (pH 7.4)/50 mM NaCl/6
mMMgCl2/1 mMDTT] and 1 Ci 5[32P]IP7 for 15 min at 37°C.
The reactions were heated at 95°C for 5 min in sample buffer
before separation by NuPAGE (Invitrogen, Carlsbad, CA). The
gels were either stained and dried, or transferred to a PVDF
membrane. Radiolabeled proteins were detected by autoradiog-
raphy. Immunoblotting using anti-Xpress (Invitrogen) or anti-
GST (Sigma, St. Louis, MO) antibodies, was performed accord-
ing to standard procedures.
GST- or hexahistidine-tagged proteins purified from S. cer-
evisiae were used directly for phosphorylation by 5[32P]IP7. The
protein (1–2g) was incubated in the presence of 5[32P]IP7, and
the reaction was performed as described above. Where indi-
cated, the purified proteins were preincubated with -phospha-
tase (400 units; New England Biolabs, Beverly, MA) at 30°C for
1 h, washed twice with PBS, and then used in a 5[32P]IP7
phosphorylation assay. GST fusion proteins purified fromE. coli,
were coupled to glutathione beads, and either incubated directly
with 5[32P]IP7 as above or were first preincubated with 12 g
of extract prepared from S. cerevisiae (strain DDY1810) at 30°C
for 1 h in IP7 phosphorylation buffer with or without 1 mMATP
or other nucleotides. Where indicated, the S. cerevisiae extract
was incubated in boiling water for 5 min, cooled, and then used
for the preincubation with purified protein. After incubation
with yeast extract, the glutathione beads were washed twice with
PBS and once with IP7 phosphorylation buffer and used for
phosphorylation by 5[32P]IP7 as described above. In some cases,
proteins purified from E. coli were first preincubated with 250
units of CK2 (New England Biolabs) in the supplied CK2
reaction buffer, along with 1 mM ATP at 30°C for 1 h, and then
washed and used for 5[32P]IP7 phosphorylation. NSR1 amino
acids 27–50 purified from E. coli cells coexpressing human
CK2A1 was used directly in 5[32P]IP7 phosphorylation assays.
Peptides were synthesized as described in SI Materials and
Methods. Synthetic peptides were used for both CK2 and ATP or
IP7 mediated phosphorylation assays. Peptide (3–6 g) was
incubated with 250 units of CK2 in CK2 phosphorylation buffer,
200 M ATP, and 1 Ci [32P]ATP at 30°C for 15–30 min. For
IP7 phosphorylation, 3–6 g of peptide was added to IP7
phosphorylation buffer and 1–2 Ci of 5[32P]IP7 at 37°C for 15
min, followed by incubation at 95°C for 5 min. The peptides were
mixed with sample buffer and resolved on a 12% gel by using the
NuPAGE system. The gels were stained by using Safe Stain
(Invitrogen), dried, and used for autoradiography. Although
peptide phosphorylation by IP7 was routinely performed at 95°C
to maximize the extent of phosphorylation, a time-dependent
increase in phosphorylation is observed at 37°C (SI Fig. 9).
Acid-Sensitivity Assay. To determine the sensitivity of CK2 and
ATP or IP7-phosphorylated NOP-2[pS] peptide to treatment
with acid, peptides were phosphorylated as described above and
then incubated with either 1 M HCl at 50°C, with 3 M HCl at
25°C, or without any acid at 25°C, for 1 h. After incubation, the
acid was neutralized with an appropriate volume of 10 MNaOH,
and the reaction was mixed with sample buffer and subjected to
NuPAGE. Phosphorylation was detected as described above.
Peptide hydrolysis in the presence of 6 M HCl, followed by
separation of amino acids by HPLC, was performed as described
in SI Materials and Methods.
-Phosphatase-Sensitivity Assay. Purified GST fusion proteins or
NOP-2[pS] peptide were phosphorylated by CK2 and [32P]ATP
or by 5[32P]IP7 as described above. After phosphorylation, the
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biotinylated NOP-2[pS] peptide was bound to streptavidin aga-
rose beads (Sigma) and washed with PBS. Protein or peptide was
then incubated in the presence of -phosphatase (400 units; New
England Biolabs) in supplied buffer according to the manufac-
turer’s instructions at 30°C for 1 h, mixed with sample buffer,
resolved by NuPAGE, and subjected to autoradiography. Ex-
pression and purification of 32[PO4]i-labeledGST fusion proteins
and their treatment with phosphatase is described in SI Materials
and Methods.
The Pro-QDiamond PhosphoproteinGel Stain (Invitrogen) was
used to determine relative levels of phosphate on the NOP-2[pS] or
NOP-2[ppS] peptides before or after treatment with -phospha-
tase. NOP-2[pS] peptide (6 g) or NOP-2[ppS] peptide (24 g)
were incubated with 400 units of -phosphatase for 1 h at 30°C and
then resolved by NuPAGE and stained with Pro-Q Diamond stain
according to the manufacturer’s instructions.
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